This study investigated the effects of morroniside on osteoporosis in ovariectomized rats. Sixty female SD rats were randomly divided into sham-operated, model group, and low-, middle- and high-dose morroniside groups. In later 4 groups, the osteoporosis of rats was induced by ovariectomy. The low-, middle-, and high-dose morroniside groups were intragastrically administrated with morroniside, with dose of 100, 200, and 400 mg/kg, respectively. After treatment for 3 months, compared with model group, in high-dose morroniside group the femur bone mineral density, maximum load and stiffness, serum calcium, estradiol and superoxide dismutase levels and femur collagen type I (COL I) protein expression level were increased, and the serum phosphorus, alkaline phosphatase and malondialdehyde levels and femur cathepsin K (Cath K) protein expression level were decreased (all P < 0.05). Morroniside has protective effects osteoporosis in ovariectomized rats, which may be related their resistance of oxidative stress and regulation of COL I and Cath K expressions.